Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Tiziana Life Sciences Announces Reduction in Microglial Activation in a Total of…
Results confirm positive signal previously reported in the first two Expanded Access patients who both subsequently demonstrated clinical improvementsPhase 2a trial in na-SPMS on track to begin in Q3 2023KOL webinar with Howard L. Weiner, M.D., Chairman of Tiziana's Scientific Advisory Board and Co-Director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital being held today at 12:30 PM ET (details below)NEW YORK, June05, 2023(GLOBE NEWSWIRE) --...
Nasdaq GlobeNewswire
05/06/2023
Dante Genomics offers new Rare Disease Health Package to help bring diagnoses to…
The Rare Disease Health Package includes pre- and post-telemedicine consultations with specialist doctors, providing access to specialists who may not be available in a patient's area. Dante removes financial barriers to care by identifying potential treatments and management strategies for rare diseases. The package also prioritizes privacy and security, with a commitment to not selling genomic and personal information and to remain in compliance with all GDPR and HIPAA regulations. The 30X…
PR Newswire
05/06/2023
Sir Elton John Joins Forces with Donatella Versace and Other Notable…
NEW YORK, June 5, 2023 /PRNewswire/ -- Sir Elton John, global superstar and Founder of the Elton John AIDS Foundation, has announced the launch of The Rocket Fund, a $125 million, three-year initiative to accelerate the Foundation's life-saving work to tackle the growing rates of HIV infections in vulnerable communities. NEW YORK,June 5, 2023/PRNewswire/ -- SirElton John, global superstar and Founder of the Elton John AIDS Foundation, has announced the launch of The Rocket Fund , a...
PR Newswire
05/06/2023
Injectafer® approved in the U.S. for the treatment of iron deficiency in…
"We are very pleased that the FDA has approved the heart failure label extension of Injectafer®, and congratulate our partner on this milestone", said Hervé Gisserot, General Manager of CSL Vifor. "Every second patient with chronic heart failure suffers from iron deficiency, with a significant number of patients either not being diagnosed or inadequately treated for iron deficiency. We are confident that Injectafer® can make a meaningful contribution to achieve key therapeutic…
PR Newswire
05/06/2023
Amolyt Pharma Announces Initiation of Phase 1 Clinical Trial of Peptide Growth…
LYON, France and CAMBRIDGE, Mass., June05, 2023(GLOBE NEWSWIRE) -- Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced the initiation of a Phase 1 clinical trial of the Company's peptide growth hormone receptor antagonist (GHRA), AZP-3813, which is being developed as a potential add-on to somatostatin analogs (SSAs) for the treatment of acromegaly. “Somatostatin analogs currently represent the standard...
Nasdaq GlobeNewswire
05/06/2023
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute…
"The Bill & Melinda Gates Medical Research Institute is committed to developing biomedical interventions that address global health concerns for those in the greatest need," said Emilio Emini, PhD, chief executive officer of the Bill & Melinda Gates Medical Research Institute. "We look forward to working with Novavax's Matrix-M™ adjuvant in some of our early-stage vaccine programs." "The Bill & Melinda Gates Medical Research Institute is committed to…
PR Newswire
05/06/2023
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics…
Analysis System and the Sartorius™ Resolute® BioSMB™ multi-column chromatography platform will give bioprocess engineers access to more comprehensive analytical data for downstream batch and continuous manufacturing, improving yields while reducing waste and driving down biomanufacturing costs. Analysis Systemand theSartorius™ Resolute ®BioSMB™ multi-column chromatography platformwill give bioprocess engineers access to more comprehensive analytical data for downstream batch...
PR Newswire
05/06/2023
More Than 450 Companies Adopt Veeva Vault eTMF for Improved Trial Efficiency and…
As regulatory and trial complexity grows, more companies are increasing transparency and inspection readiness with Vault eTMF. Veeva Systems (NYSE: VEEV) is helping organizations address critical TMF challenges with innovations, including: As regulatory and trial complexity grows, more companies are increasing transparency and inspection readiness with Vault eTMF.Veeva Systems(NYSE: VEEV) is helping organizations address critical TMF challenges with innovations, including: "We're excited...
PR Newswire
05/06/2023
NRx Pharmaceuticals, Lotus Pharmaceuticals and Alvogen Inc. Announce…
NRx Pharmaceuticals, Lotus Pharmaceuticals, and Alvogen to collaborate on the further development and commercialization of NRX-101 for suicidal treatment-resistant bipolar depression (S-TRBD) for global marketsLotus Pharmaceuticals will acquire worldwide rights for NRX-101 for S-TRBD and will be responsible for commercialization of NRX-101 in markets outside the US through Lotus's direct presence in certain Asian markets or through their export division, which currently has...
Nasdaq GlobeNewswire
05/06/2023
Domain Therapeutics announces nomination of first-in-class PAR2 NAM candidate…
Domain Therapeuticsannounces nomination of first-in-class PAR2 NAMcandidate,DT-9045 ,to unlock new cancer treatmentpossibilitiesDT-9045 is a unique drug candidate due to its competitive differentiating pharmacological featuresStart of Phase 1 ascending dose studies in recurrent or metastatic solid tumors with DT-9045 is expected by mid-2025DT-9045 builds upon the Company's growing pipeline which includes the clinical-stage drug candidates, M1069 (A2a/A2b...
Nasdaq GlobeNewswire
05/06/2023
Global Functional Fitness Equipment Market Anticipated to Garner $2,73,315.2…
As per the report published by Research Dive, the global functional fitness equipment market is expected to register a revenue of $2,73,315.2 million by 2031, growing at a CAGR of 47.7% during the forecast period 2022-2031. As per the report published by Research Dive, theglobal functional fitness equipment market is expected to register a revenue of$2,73,315.2 millionby 2031, growing at a CAGR of 47.7% during the forecast period 2022-2031. Segments of the Functional Fitness...
PR Newswire
05/06/2023
The Department of Health - Abu Dhabi and Eli Lilly Suisse S.A sign Declaration…
Dr. Asma Al Mannaei said: "Through international collaborations, Abu Dhabi seeks to lead research groups supported by global partners to explore the resilience and sustainability of the healthcare sector worldwide, as well as provide quality care to patients. Under the directives of our wise leadership, Abu Dhabi is paving the way for the region's transformative journey through innovation, life science and valuable partnerships with global players in the field. The Department of Health –…
PR Newswire
05/06/2023
Global Cyclic Olefin Copolymer Market to Continue on its Pandemic-Period Growth…
As per the report published by Research Dive, the global cyclic olefin copolymer market is expected to register a revenue of $1,410.0 million by 2031 at a CAGR of 5.5% during the forecast period 2022-2031. As per the report published by Research Dive, theglobal cyclic olefin copolymer market is expected to register a revenue of$1,410.0 millionby 2031 at a CAGR of 5.5% during the forecast period 2022-2031. Segments of the Cyclic Olefin Copolymer Market The report has divided...
PR Newswire
05/06/2023
Home Healthcare Market to Hit $666.9 Billion by 2030: Grand View Research, Inc.
Read 252 page market research report, "Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 252 page market research report, " Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular…
PR Newswire
05/06/2023
Cell Culture Flasks Market to Surpass USD 1427.14 Million By 2031| Growth Market…
Download PDF Sample here: https://growthmarketreports.com/request-sample/4853 Download PDF Sample here: https://growthmarketreports.com/request-sample/4853 The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics. It provides an in-depth analysis of the market segments, which include type, material, sterility, closure cap, sales channel, and competitor analysis. This report also includes a...
PR Newswire
05/06/2023
Dietary Supplements Market worth $239.4 billion by 2028 - Exclusive Report by…
Browse in-depth TOC on "Dietary Supplements Market"380 – Tables45 – Figures350 – Pages Browse in-depth TOC on "Dietary Supplements Market" 380 – Tables 45 – Figures 350 – Pages The high demand for vitamins for all age groups drives the market Vitamins are required in small quantities, to maintain health and necessary function of the human body. Different vitamins play vital roles like maintaining bone density, proper hormonal activity, weight, and muscle mass in all humans...
PR Newswire
05/06/2023
Nexstim Receives an NBS System Order from a Finnish Hospital
Press release, Helsinki , 5 June 2023 at 12 PM(EEST) Nexstim Receives an NBS System Order from a Finnish Hospital Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received an order for an NBS 5 system from a hospital in Finland.The customer is an experienced user of TMS, now acquiring a new NBS 5 (Navigated Brain Stimulation) system with therapy capabilities. Nexstim's NBS system can be used, for example, in planning neurosurgery or radiation therapy after a patient...
Nasdaq GlobeNewswire
05/06/2023
Lunit and Capio S:t Göran Hospital Collaborate to Address Radiologist Shortage…
Capio S:t Göran Hospital is Sweden's largest private hospital with over 2,300 medical staff. It is operated by Capio, a part of the Ramsay Santé group. The hospital delivers both planned and emergency medical care services to 100,000 patients from the region of Stockholm. Capio S:t Göran Hospital isSweden'slargest private hospital with over 2,300 medical staff. It is operated by Capio, a part of the Ramsay Santé group. The hospital delivers both planned and emergency medical care services...
PR Newswire
05/06/2023
PhenomeX to Participate in Antibody Engineering & Therapeutics Europe 2023
At the conference, the Company will feature its optofluidic and proteomic technologies, including its recently launched Beacon Select™ technology, in booth #19 and attendees can explore demonstrations and learn more about how PhenomeX's products can advance and accelerate our understanding of cellular function along the continuum of scientific discovery, bioprocessing, clinical research, and immunotherapy development. At the conference, the Company will feature its optofluidic and proteomic...
PR Newswire
05/06/2023
MAXIMA GRUPĖ companies has a new management team
th, Manfredas Dargužis becomes the new CEO of MAXIMA GRUPĖ, and Jolanta Bivainytė assumes the role of CEO for MAXIMA LT. Manfredas Dargužis, formerly the CEO of AKROPOLIS GROUP, has been appointed as the CEO of MAXIMA GRUPĖ and has also been elected Chairman of the Management Board. Starting from June 5 th, Manfredas Dargužis takes over the management of MAXIMA GRUPĖ from Agnė Voverė, who has been appointed as the Head of the Baltic region, with responsibility for the "Maxima"…
Nasdaq GlobeNewswire
05/06/2023
ERYTECH announces that Akkadian has initiated proceedings to postpone the vote…
ERYTECH announces that Akkadianhas initiated proceedings to postpone the voteon the merger with Pherecydes Cambridge, MA (U.S.) and Lyon (France),June 5 , 2023– ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, todayannounced that Akkadian Partners has initiated legal proceedings to obtain the postponement of the vote on the...
Nasdaq GlobeNewswire
05/06/2023
BBS-Bioactive Bone Substitutes Plc: BBS arranges a rights offering of…
BBS-Bioactive Bone Substitutes Plc, Company Announcement, Insider information, 5 June 2023 at 09.00 a.m. EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN PART, DIRECTLY OR INDIRECTLY, IN THE USA, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL. BBS-Bioactive Bone Substitutes Plc: BBS arranges a rightsoffering of approximately maximum 2.9 MEUR Based on authorization...
Nasdaq GlobeNewswire
05/06/2023
Novo Nordisk enters exclusive negotiations to acquire a controlling stake in…
Novo Nordisk has entered intoexclusive negotiations with BIO JAG, BIOCORP's main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.2% of its theoretical voting rights, at a price of 35.00 Euros per share. Certain minority shareholders, representing 19.0% of the share capital and 13.07% of the theoretical voting rights of BIOCORP, have committed to transfer shares to Novo Nordisk upon completion of...
Nasdaq GlobeNewswire
05/06/2023
Edward W. Marple, A.B. (Harvard), MBA (Virginia), joins Paraza Pharma as…
"I am delighted by the opportunity to join Arshad and collaborate with the Paraza team as they continue to grow and expand Paraza's ability to deliver wonderful science and innovative drug discovery solutions to their client-partners." said Mr. Marple. "I am delighted by the opportunity to join Arshad and collaborate with the Paraza team as they continue to grow and expand Paraza's ability to deliver wonderful science and innovative drug discovery solutions to their…
PR Newswire
05/06/2023
Altri Comunicati